Literature DB >> 19817017

Hepatitis B vaccines.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19817017

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN： 0049-8114


× No keyword cloud information.
  95 in total

1.  A vesicular stomatitis virus-based hepatitis B virus vaccine vector provides protection against challenge in a single dose.

Authors:  Melissa A Cobleigh; Linda Buonocore; Susan L Uprichard; John K Rose; Michael D Robek
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

2.  Cellular inhibitor of apoptosis proteins prevent clearance of hepatitis B virus.

Authors:  Gregor Ebert; Simon Preston; Cody Allison; James Cooney; Jesse G Toe; Michael D Stutz; Samar Ojaimi; Hamish W Scott; Nikola Baschuk; Ueli Nachbur; Joseph Torresi; Ruth Chin; Danielle Colledge; Xin Li; Nadia Warner; Peter Revill; Scott Bowden; John Silke; C Glenn Begley; Marc Pellegrini
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-20       Impact factor: 11.205

3.  A comparative clinical study to assess safety and reactogenicity of a DTwP-HepB+Hib vaccine.

Authors:  Shashank Dalvi; Prasad S Kulkarni; M A Phadke; S S More; Sanjay K Lalwani; Dipty Jain; Mamta Manglani; B S Garg; Mohan K Doibale; C T Deshmukh
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  Testing and Linking Foreign-Born People with Chronic Hepatitis B Virus Infection to Care at Nine U.S. Programs, 2012-2014.

Authors:  Aaron M Harris; Ben T Schoenbachler; Gilberto Ramirez; Claudia Vellozzi; Geoff A Beckett
Journal:  Public Health Rep       Date:  2016 May-Jun       Impact factor: 2.792

5.  Comparison of the effect of two different doses of recombinant hepatitis B vaccine on immunogenicity in healthy adults.

Authors:  Jing Li; Jun Yao; Huan Shan; Yongdi Chen; Zheng-gang Jiang; Jing-jing Ren; Kai-jin Xu; Bing Ruan; Shi-gui Yang; Bing Wang; Tian-sheng Xie; Qian Li
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

6.  Evaluation of storing hepatitis B vaccine outside the cold chain in the Solomon Islands: Identifying opportunities and barriers to implementation.

Authors:  Lucy Breakwell; Jenniffer Anga; Ibrahim Dadari; Nahad Sadr-Azodi; Divinal Ogaoga; Minal Patel
Journal:  Vaccine       Date:  2017-04-18       Impact factor: 3.641

7.  Perinatal hepatitis B prevention program in Shandong Province, China. Evaluation and progress.

Authors:  Li Zhang; Stephen Ko; Jingjing Lv; Feng Ji; Bingyu Yan; Fujie Xu; Aiqiang Xu
Journal:  Hum Vaccin Immunother       Date:  2014-11-06       Impact factor: 3.452

8.  The persistence of anti-HBs antibody and anamnestic response 20 years after primary vaccination with recombinant hepatitis B vaccine at infancy.

Authors:  Masoomeh Bagheri-Jamebozorgi; Jila Keshavarz; Maryam Nemati; Saeed Mohammadi-Hossainabad; Mohammad-Taghi Rezayati; Mohsen Nejad-Ghaderi; Ahmad Jamalizadeh; Fazel Shokri; Abdollah Jafarzadeh
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

9.  Normal or defective immune response to Hepatitis B vaccine in patients with diabetes and celiac disease.

Authors:  Giovanna Zanoni; Giovanna Contreas; Enrico Valletta; Oretta Gabrielli; Carlo Mengoli; Dino Veneri
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

Review 10.  Emerging challenges in managing hepatitis B in HIV patients.

Authors:  Vincent Soriano; Pablo Labarga; Carmen de Mendoza; José M Peña; José V Fernández-Montero; Laura Benítez; Isabella Esposito; Pablo Barreiro
Journal:  Curr HIV/AIDS Rep       Date:  2015-09       Impact factor: 5.071
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.